Skip to content

Clinical trials

Carcinoma, Transitional Cell trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Transitional Cell Country / region: Hungary Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20161
20172
20181
20194
20211
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting2
Recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Basilea Pharmaceutica1
Bayer1
EMD Serono Research & Development Institute, Inc.1
G1 Therapeutics, Inc.1
Hoffmann-La Roche1
Incyte Corporation1
Merck Sharp & Dohme LLC1
Pfizer1
Rainier Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Transitional Cell13
Urinary Bladder Neoplasms7
Carcinoma, Non-Small-Cell Lung2
Acrocephalosyndactylia1
Carcinoma, Hepatocellular1
Carcinoma, Renal Cell1
Neoplasm Metastasis1
Ovarian Neoplasms1
Small Cell Lung Carcinoma1
Urethral Neoplasms1

Trials

Showing 76 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.